Sun Pharma To Foray Into Large European Markets To Sell Hospital Products
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Sun Pharmaceutical - the most highly valued Indian drug company - is soon establishing its direct presence in Europe. The move comes years after Sun Pharma's top Indian rivals Ranbaxy, Dr. Reddy's and Wockhardt set up their operations in Europe through organic route or by acquiring established generic drug businesses